Weixue Si
- Co-authors
- Xinghuan WangYu WangBusen WangJianying HuangJinlong ZhangJun ZhangChang ChenShipo Wu
- Topics
- Glycosylation and Glycoproteins Research (1 paper)SARS-CoV-2 and COVID-19 Research (1 paper)Virus-based gene therapy research (1 paper)
- Journals
- ACS Applied Materials & InterfacesThe Lancet Infectious DiseasesEuropean Journal of Medicinal Chemistry
- Partner nations
- China
In The Last Decade
Weixue Si
2 papers receiving 188 citations
Hit Papers
Peers
Comparison fields: 5 of 49
- Infectious Diseases 136
- Molecular Biology 44
- Epidemiology 40
- Health 36
- Immunology 35
Countries citing papers authored by Weixue Si
This map shows the geographic impact of Weixue Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weixue Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weixue Si more than expected).
Fields of papers citing papers by Weixue Si
This network shows the impact of papers produced by Weixue Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weixue Si. The network helps show where Weixue Si may publish in the future.
Co-authorship network of co-authors of Weixue Si
This figure shows the co-authorship network connecting the top 25 collaborators of Weixue Si. A scholar is included among the top collaborators of Weixue Si based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weixue Si. Weixue Si is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trialbreakdown → | 192 |
About Weixue Si
Weixue Si is a scholar working on Oncology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging, having authored 3 papers that have together received 193 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Infectious Diseases (136 citations), Health (36 citations) and Animal Science and Zoology (25 citations). Weixue Si has collaborated with scholars based in China. Frequent co-authors include Xinghuan Wang, Yu Wang, Busen Wang, Jianying Huang, Jinlong Zhang, Jun Zhang, Chang Chen, Shipo Wu, Jianyuan Wu and Zhe Zhang. Their work appears in journals such as ACS Applied Materials & Interfaces, The Lancet Infectious Diseases and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.